Skip to content

Intrinsic cognition and neural mechanism of abnormal negative expression recognition in schizophrenia

Intrinsic cognition and neural mechanism of abnormal negative expression recognition in schizophrenia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029167
Enrollment
Unknown
Registered
2020-01-17
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-episode Schizophrenia

Interventions

Gold Standard:the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
emotion&#32
model&#32
based&#32
on&#32
the&#32
circuit

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: First-episode schizophrenia with high social cognition group: 1. Meet the diagnostic criteria for schizophrenia according to the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); 2. MSCEIT scale score> 59.2 points (consensus points); 3. Aged 18 to 45 years, able to cooperate with task-state functional magnetic resonance testing; 4. First onset, not receiving systemic antipsychotic therapy (not receiving sufficient medication for more than 3 months or never receiving medication); 5. Wechsler Intelligence Scale assesses IQ> 70. First-episode schizophrenia with low social cognitive group: 1. Meet the diagnostic criteria for schizophrenia according to the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); 2. MSCEIT scale score 70. Healthy control group: 1. Aged 18 to 45 years; 2. Wechsler Intelligence Scale assesses IQ> 70; 3. No mental illness.

Exclusion criteria

Exclusion criteria: 1. Contraindications to magnetic resonance scanning; 2. Mental retardation and neurological diseases, major physical diseases; 3. History of traumatic brain injury, MRI examination showed abnormal brain structure; 4. A history of alcohol or drug abuse and dependence; 5. Accept MECT and long-term use of anticholinergic, benzodiazepines and other drugs that may affect cognitive function.

Design outcomes

Primary

MeasureTime frame
Magnetic resonance image of head;

Secondary

MeasureTime frame
Intelligence Quotient;neural cognitive function;social cognitive function;clinical symptoms;social function;

Countries

China

Contacts

Public ContactLu Zheng

Tongji Hospital of Tongji University

luzheng@tongji.edu.cn+86 13671902719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026